NanoViricides

NanoViricides is a global leader in developing nanomedicines targeting viruses. Our unique NanoViricides® platform technology defines a novel mechanism for achieving first-in-class drugs against viruses. NanoViricides are designed to specifically attack enveloped virus particles at the same sites they use to bind to cells, disassembling them and blocking the reinfection cycle, surpassing the effects of antibodies and immunotherapies. NanoViricides can also be engineered to deliver antiviral payloads to infected cells while avoiding uninfected cells, interrupting the replication cycle without causing toxicity. Our distinctive biomimetic approach enables the creation of drugs that viruses are highly unlikely to escape due to mutations. NanoViricides is one of the few biopharmaceutical companies with its own multi-kilogram c-GMP-capable drug substance and drug product manufacturing facility located in Shelton, Connecticut.